4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-001712
Chief Legal Officer acquired 45,518 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ali-Jackson Kamil · Chief Legal Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Exercise or conversion : show line 1 in the form | +3,875 | 118,571 | D |
| 2022-01-03 | Exercise or conversion : show line 2 in the form | +27,905 | 146,476 | D |
| 2022-01-03 | Exercise or conversion : show line 3 in the form | +6,638 | 153,114 | D |
| 2022-01-03 | Exercise or conversion : show line 4 in the form | +7,100 | 160,214 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −3,875 | 0 | D |
| 2022-01-03 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −27,905 | 0 | D |
| 2022-01-03 | Exercise or conversion : show line 7 in the form Restricted Stock Unit | −6,638 | 0 | D |
| 2022-01-03 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −7,100 | 0 | D |
Loading xslF345X03/doc4.xml…